U.K. limits infant formula claims
This article was originally published in The Tan Sheet
Label statements such as "closer than ever to breast milk" and "nucleotides help growth and the immune system" are no longer allowed on infant formula sold in the U.K., according to the Local Authorities Coordinators of Regulatory Services. The governmental body has provided additional advice to marketers of infant formula that expands upon a 1997 regulation and limits the number of claims manufacturers can make and disallows any claims relating to the special composition of the formula. Examples of other claims that are no longer permissible include "omega-3 LCPs for development" and "beta carotene helps the immune system"...
You may also be interested in...
AMAG outlines plans for retrospective real-world evidence studies, and possibly a new placebo-controlled trial with a primary endpoint of preterm birth <32 weeks, in a filing opposing the Center for Drug Evaluation and Research’s proposal to withdraw the drug.
The leading Korean pharma firm’s oral, third-generation EGFR-TKI is approved in the country, providing a new option for patients with advanced NSCLC and increasing hopes for global approvals given an ongoing global Phase III combination trial led by partner J&J.
DePuy Synthes expects its Velys robotic-assisted system to be cost-effective, easy-to-use and to be well-suited for use in ambulatory surgery centers.